litlas
Log inCreate account

Ivan Stamenkovic

Active 1984–2024

105
Papers
36,064
Citations
88
h-index
104
i10-index

Citations

Citations per year for Ivan Stamenkovic1936: 1 citations1984: 2 citations1986: 2 citations1987: 3 citations1988: 13 citations1989: 34 citations1990: 85 citations1991: 129 citations1992: 167 citations1993: 282 citations1994: 310 citations1995: 294 citations1996: 291 citations1997: 295 citations1998: 286 citations1999: 260 citations2000: 298 citations2001: 310 citations2002: 330 citations2003: 307 citations2004: 311 citations2005: 270 citations2006: 223 citations2007: 244 citations2008: 258 citations2009: 234 citations2010: 324 citations2011: 320 citations2012: 292 citations2013: 329 citations2014: 376 citations2015: 365 citations2016: 283 citations2017: 273 citations2018: 292 citations2019: 801 citations2020: 887 citations2021: 948 citations2022: 766 citations2023: 578 citations2024: 810 citations2025: 437 citations2026: 27 citations1937–1983: no citations, so these years are not shown1985: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,680 citing papers, 31.9% of this breakdownChina: 1,378 citing papers, 9.4% of this breakdownGermany: 968 citing papers, 6.6% of this breakdownUnited Kingdom: 957 citing papers, 6.5% of this breakdownCanada: 573 citing papers, 3.9% of this breakdownItaly: 549 citing papers, 3.7% of this breakdownJapan: 511 citing papers, 3.5% of this breakdownFrance: 478 citing papers, 3.3% of this breakdownSwitzerland: 332 citing papers, 2.3% of this breakdownAustralia: 322 citing papers, 2.2% of this breakdownNetherlands: 322 citing papers, 2.2% of this breakdownSpain: 290 citing papers, 2% of this breakdown
0%31.9%Other 22.5%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology47%
  • Medicine36.3%
  • Immunology and Microbiology8.6%
  • Computer Science2.4%
  • Neuroscience1.8%
  • Engineering1.2%
  • Other2.7%

Topics

  • Proteoglycans and glycosaminoglycans research3.7%
  • Cell Adhesion Molecules Research3.4%
  • Glycosylation and Glycoproteins Research3.1%
  • Cancer Cells and Metastasis2.9%
  • Protease and Inhibitor Mechanisms2.7%
  • Glioma Diagnosis and Treatment2.5%
  • Other81.7%

Coauthors

All papers

Open in search
  1. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

    Authors: Cyril Neftel, Julie Laffy, Mariella G. Filbin, Toshiro Hara, Marni E. Shore, Gilbert J. Rahme, Alyssa Richman, Dana Silverbush, McKenzie Shaw, Christine Hebert, John DeWitt, Simon Gritsch, Elizabeth M. Perez, L. Nicolas Gonzalez Castro, Xiaoyang Lan, Nicholas Druck, Christopher Rodman, Danielle Dionne, Alexander Kaplan, Mia Bertalan, Julia L. Small, Kristine Pelton, Sarah Becker, Dennis M. Bonal, Quang‐Dé Nguyen, Rachel L. Servis, Jeremy Man Fung, Ravindra Mylvaganam, Lisa Mayr, Johannes Gojo, Christine Haberler, René Geyeregger, Thomas Czech, Irene Slavc, Brian V. Nahed, William T. Curry, Bob S. Carter, Hiroaki Wakimoto, Priscilla K. Brastianos, Tracy T. Batchelor, Anat Stemmer‐Rachamimov, Maria Martinez‐Lage, Matthew P. Frosch, Ivan Stamenkovic, Nicolò Riggi, Esther Rheinbay, Michelle Monje, Orit Rozenblatt–Rosen, Daniel P. Cahill, Anoop P. Patel, Tony Hunter, Inder M. Verma, Keith L. Ligon, David N. Louis, Aviv Regev, B Bernstein, Itay Tirosh, Mario L. Suvà - Cell 2019 cited by 2,988

  2. Systematic identification of genomic markers of drug sensitivity in cancer cells

    Authors: Mathew J. Garnett, Elena J. Edelman, Sonja J. Heidorn, Chris Greenman, Anahita Dastur, King Wai Lau, Patricia Greninger, I. Richard Thompson, Xi Luo, Jorge Soares, Qingsong Liu, Francesco Iorio, Didier Surdez, Li Chen, Randy Milano, Graham R. Bignell, Ah Ting Tam, Helen Davies, Jesse A. Stevenson, Syd Barthorpe, Stephen Lutz, Fiona Kogera, Karl Lawrence, Anne McLaren-Douglas, Xeni Mitropoulos, Tatiana Mironenko, Helen Thi, Laura Richardson, Wenjun Zhou, Frances Jewitt, Tinghu Zhang, Patrick O’Brien, Jessica L. Boisvert, Stacey Price, Wooyoung Hur, Wanjuan Yang, Xianming Deng, Adam P. Butler, Hwan Geun Choi, Jae Won Chang, José Baselga, Ivan Stamenkovic, Jeffrey A. Engelman, Sreenath V. Sharma, Olivier Delattre, Julio Sáez-Rodríguez, Nathanael S. Gray, Jeffrey Settleman, P. Andrew Futreal, Daniel A. Haber, Michael R. Stratton, Sridhar Ramaswamy, Ultan McDermott, Cyril H. Benes - Nature 2012 cited by 2,601

  3. Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain

    Authors: Gaylor Boulay, Gabriel J. Sandoval, Nicolò Riggi, Sowmya Iyer, Rémi Buisson, Beverly Naigles, Mary E. Awad, Shruthi Rengarajan, Angela Volorio, Matthew J. McBride, Liliane C. Broye, Lee Zou, Ivan Stamenkovic, Cigall Kadoch, Miguel N. Rivera - Cell 2017 cited by 492

  4. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis

    Authors: Qin Yu, Ivan Stamenkovic - Genes & Development 2000 cited by 1,716

  5. Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells

    Authors: Michalina Janiszewska, Mario L. Suvà, Nicolò Riggi, Riekelt H. Houtkooper, Johan Auwerx, Virginie Clément‐Schatlo, Ivan Radovanovic, Esther Rheinbay, Paolo Provero, Ivan Stamenkovic - Genes & Development 2012 cited by 458

  6. CD44 is the principal cell surface receptor for hyaluronate

    Authors: Alejandro Aruffo, Ivan Stamenkovic, Michael Melnick, Charles B. Underhill, Brian Seed - Cell 1990 cited by 2,465

  7. EWS-FLI1 Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma

    Authors: Nicolò Riggi, Birgit Knoechel, Shawn Gillespie, Esther Rheinbay, Gaylor Boulay, Mario L. Suvà, Nikki E. Rossetti, Wannaporn E. Boonseng, Ozgur Oksuz, Edward Cook, Aurélie Formey, Anoop P. Patel, Melissa Gymrek, Vishal Thapar, Vikram Deshpande, David T. Ting, Francis J. Hornicek, G. Petur Nielsen, Ivan Stamenkovic, Martin J. Aryee, B Bernstein, Miguel N. Rivera - Cancer Cell 2014 cited by 468

  8. IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer

    Authors: Nils Degrauwe, Mario-Luca Suvà, Michalina Janiszewska, Nicolò Riggi, Ivan Stamenkovic - Genes & Development 2016 cited by 349

  9. Ewing’s Sarcoma

    Authors: Nicolò Riggi, Mario L. Suvà, Ivan Stamenkovic - New England Journal of Medicine 2021 cited by 332

  10. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.

    Authors: Qin Yu, Ivan Stamenkovic - 2000 cited by 1,956

  11. Extracellular matrix remodelling: the role of matrix metalloproteinases

    Authors: Ivan Stamenkovic - The Journal of Pathology 2003 cited by 1,128

  12. Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma

    Authors: Livnat Jerby-Arnon, Cyril Neftel, Marni E. Shore, Hannah Weisman, Nathan D. Mathewson, Matthew J. McBride, Brian J. Haas, Benjamin Izar, Angela Volorio, Gaylor Boulay, Luisa Cironi, Alyssa Richman, Liliane C. Broye, Joseph M. Gurski, Christina C. Luo, Ravindra Mylvaganam, Lan Nguyễn, Shaolin Mei, Johannes C. Melms, C Georgescu, Ofir Cohen, Jorge E. Buendia-Buendia, Åsa Segerstolpe, Malika Sud, Michael S. Cuoco, Danny Labes, Simon Gritsch, Daniel R. Zollinger, Nicole Ortogero, Joseph Beechem, G. Petur Nielsen, Ivan Chebib, Tu Nguyen‐Ngoc, Michael Montemurro, Gregory M. Coté, Edwin Choy, Igor Letovanec, Stéphane Cherix, Nikhil Wagle, Peter K. Sorger, Alex B. Haynes, John T. Mullen, Ivan Stamenkovic, Miguel N. Rivera, Cigall Kadoch, Kai W. Wucherpfennig, Orit Rozenblatt–Rosen, Mario L. Suvà, Nicolò Riggi, Aviv Regev - Nature Medicine 2021 cited by 127

  13. Functional structure and composition of the extracellular matrix

    Authors: Fred T. Bosman, Ivan Stamenkovic - The Journal of Pathology 2003 cited by 809

  14. Mesenchymal stromal cells in cancer: a review of their immunomodulatory functions and dual effects on tumor progression

    Authors: Sabine Galland, Ivan Stamenkovic - The Journal of Pathology 2019 cited by 165

  15. EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance

    Authors: Mario-Luca Suvà, Nicolò Riggi, Michalina Janiszewska, Ivan Radovanovic, Paolo Provero, Jean‐Christophe Stehle, Karine Baumer, Marie‐Aude Le Bitoux, Denis Marino, Luisa Cironi, Víctor E. Márquez, Virginie Clément, Ivan Stamenkovic - Cancer Research 2009 cited by 470

  16. Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identity

    Authors: Rajendran Sanalkumar, Rui Dong, Lukuo Lee, Yu‐Hang Xing, Sowmya Iyer, Igor Letovanec, Stefano La Rosa, Giovanna Finzi, Elettra Musolino, Roberto Papait, Ivan Chebib, G. Petur Nielsen, Raffaele Renella, Gregory M. Coté, Edwin Choy, Martin J. Aryee, Kimberly Stegmaier, Ivan Stamenkovic, Miguel N. Rivera, Nicolò Riggi - Science Advances 2023 cited by 38

  17. Malarial Hemozoin Is a Nalp3 Inflammasome Activating Danger Signal

    Authors: Catherine Dostert, Greta Guarda, Jackeline F. Romero, Philippe Menu, Olaf Groß, Aubry Tardivel, Mario-Luca Suvà, Jean‐Christophe Stehle, Manfred Köpf, Ivan Stamenkovic, Giampietro Corradin, Jürg Tschopp - PLoS ONE 2009 cited by 388

  18. Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to Treatment

    Authors: Nicolò Riggi, Michel Aguet, Ivan Stamenkovic - Annual Review of Pathology Mechanisms of Disease 2017 cited by 124

  19. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion

    Authors: Qin Yu, Ivan Stamenkovic - Genes & Development 1999 cited by 705

  20. The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependencies

    Authors: Gaylor Boulay, Luisa Cironi, Sara P. Garcia, Shruthi Rengarajan, Yu‐Hang Xing, Lukuo Lee, Mary E. Awad, Beverly Naigles, Sowmya Iyer, Liliane C. Broye, Tugba Keskin, Alexandra Cauderay, Carlo Fusco, Igor Letovanec, Ivan Chebib, Petur Nielsen, Stéphane Tercier, Stéphane Cherix, Tu Nguyen‐Ngoc, Gregory M. Coté, Edwin Choy, Paolo Provero, Mario L. Suvà, Miguel N. Rivera, Ivan Stamenkovic, Nicolò Riggi - Life Science Alliance 2020 cited by 44

  21. Identification of Prognostic Molecular Features in the Reactive Stroma of Human Breast and Prostate Cancer

    Authors: Anne Planche, Marina Bacac, Paolo Provero, Carlo Fusco, Mauro Delorenzi, Jean‐Christophe Stehle, Ivan Stamenkovic - PLoS ONE 2011 cited by 174

  22. Tumor-Derived Mesenchymal Stem Cells Use Distinct Mechanisms to Block the Activity of Natural Killer Cell Subsets

    Authors: Sabine Galland, Joanna Vuille, Patricia Martin, Igor Letovanec, Anne Caignard, Giulia Fregni, Ivan Stamenkovic - Cell Reports 2017 cited by 109

  23. EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells

    Authors: Nicolò Riggi, Mario-Luca Suvà, Domizio Suvà, Luisa Cironi, Paolo Provero, Stéphane Tercier, Jean‐Marc Joseph, Jean‐Christophe Stehle, Karine Baumer, Vincent Kindler, Ivan Stamenkovic - Cancer Research 2008 cited by 334

  24. Hyaluronate Fragments Reverse Skin Atrophy by a CD44-Dependent Mechanism

    Authors: Gürkan Kaya, Christian Tran, Olivier Sorg, Raymonde Hotz, Denise Grand, Pierre Carraux, Liliane Didierjean, Ivan Stamenkovic, Jean‐Hilaire Saurat - PLoS Medicine 2006 cited by 147